These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31273483)

  • 1. Repeatability of tumor blood flow quantification with
    Jochumsen MR; Bouchelouche K; Nielsen KB; Frøkiær J; Borre M; Sörensen J; Tolbod LP
    EJNMMI Res; 2019 Jul; 9(1):58. PubMed ID: 31273483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Tumor Perfusion Imaging with
    Jochumsen MR; Tolbod LP; Pedersen BG; Nielsen MM; Høyer S; Frøkiær J; Borre M; Bouchelouche K; Sörensen J
    J Nucl Med; 2019 Aug; 60(8):1059-1065. PubMed ID: 30683762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer.
    Oprea-Lager DE; Kramer G; van de Ven PM; van den Eertwegh AJ; van Moorselaar RJ; Schober P; Hoekstra OS; Lammertsma AA; Boellaard R
    J Nucl Med; 2016 May; 57(5):721-7. PubMed ID: 26697964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na
    Jochumsen MR; Sörensen J; Pedersen BG; Nyengaard JR; Krag SRP; Frøkiær J; Borre M; Bouchelouche K; Tolbod LP
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):532-542. PubMed ID: 32808078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential synergy between PSMA uptake and tumour blood flow for prediction of human prostate cancer aggressiveness.
    Jochumsen MR; Sörensen J; Tolbod LP; Pedersen BG; Frøkiær J; Borre M; Bouchelouche K
    EJNMMI Res; 2021 Feb; 11(1):12. PubMed ID: 33559792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
    Kramer GM; Frings V; Hoetjes N; Hoekstra OS; Smit EF; de Langen AJ; Boellaard R
    J Nucl Med; 2016 Sep; 57(9):1343-9. PubMed ID: 27103020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic modeling of
    Ringheim A; Campos Neto GC; Anazodo U; Cui L; da Cunha ML; Vitor T; Martins KM; Miranda ACC; de Barboza MF; Fuscaldi LL; Lemos GC; Colombo Junior JR; Baroni RH
    EJNMMI Res; 2020 Feb; 10(1):12. PubMed ID: 32140850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
    Reynolds HM; Williams S; Jackson P; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Haworth A
    BJU Int; 2019 Jun; 123(6):1020-1030. PubMed ID: 30536698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Early and Late [
    Hohberg M; Kobe C; Täger P; Hammes J; Schmidt M; Dietlein F; Wild M; Heidenreich A; Drzezga A; Dietlein M
    Mol Imaging Biol; 2019 Jun; 21(3):558-566. PubMed ID: 30105521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
    Lin C; Bradshaw T; Perk T; Harmon S; Eickhoff J; Jallow N; Choyke PL; Dahut WL; Larson S; Humm JL; Perlman S; Apolo AB; Morris MJ; Liu G; Jeraj R
    J Nucl Med; 2016 Dec; 57(12):1872-1879. PubMed ID: 27445292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and radiation dosimetry of [
    Hohberg M; Kobe C; Krapf P; Täger P; Hammes J; Dietlein F; Zlatopolskiy BD; Endepols H; Wild M; Neubauer S; Heidenreich A; Neumaier B; Drzezga A; Dietlein M
    EJNMMI Res; 2019 Jul; 9(1):66. PubMed ID: 31346821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
    Weber WA; Gatsonis CA; Mozley PD; Hanna LG; Shields AF; Aberle DR; Govindan R; Torigian DA; Karp JS; Yu JQ; Subramaniam RM; Halvorsen RA; Siegel BA; ;
    J Nucl Med; 2015 Aug; 56(8):1137-43. PubMed ID: 25908829
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
    J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
    [No Abstract]   [Full Text] [Related]  

  • 15. (15)O-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases.
    Lubberink M; Golla SS; Jonasson M; Rubin K; Glimelius B; Sörensen J; Nygren P
    J Nucl Med; 2015 Aug; 56(8):1144-9. PubMed ID: 26069310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of rubidium-82 PET/CT for renal perfusion determination in healthy subjects.
    Langaa SS; Mose FH; Fynbo CA; Theil J; Bech JN
    BMC Nephrol; 2022 Nov; 23(1):379. PubMed ID: 36443713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
    Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L
    BJU Int; 2020 Apr; 125(4):515-524. PubMed ID: 31957122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Simplified Methods for Quantification of
    Kramer GM; Yaqub M; Vargas HA; Schuit RC; Windhorst AD; van den Eertwegh AJM; van der Veldt AAM; Bergman AM; Burnazi EM; Lewis JS; Chua S; Staton KD; Beattie BJ; Humm JL; Davis ID; Weickhardt AJ; Scott AM; Morris MJ; Hoekstra OS; Lammertsma AA
    J Nucl Med; 2019 Sep; 60(9):1221-1227. PubMed ID: 30850488
    [No Abstract]   [Full Text] [Related]  

  • 19.
    von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
    Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimally Repeatable Kinetic Model Variant for Myocardial Blood Flow Measurements with
    Ocneanu AF; deKemp RA; Renaud JM; Adler A; Beanlands RS; Klein R
    Comput Math Methods Med; 2017; 2017():6810626. PubMed ID: 28293274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.